British Columbia's Therapeutic Initiative -- a 14-year-old government funded agency that provides independent advice on prescription drugs -- may be replaced by the B.C. Liberal government.The agency has a stellar...
created by mike_yvr | 1 year ago | updated 1 year ago 560 views | 26 recommendations | 2 comments
"The Food and Drug Administration and the U.S. Marshals Service seized more than $300,000 of supplements and drugs stored at St. Louis manufacturer General Therapeutics after U.S. Attorney Catherine Hanaway filed a civil forfeiture suit and obtained a warrant to arrest and...
created by comoms | 2 years ago 444 views | 0 recommendations | 0 comments
""We are pleased to extend our relationship with MedImmune, a world-leading biologics business and the cornerstone to AstraZeneca's plans to establish a major international presence in the research and development of biological therapeutics," said Dr. Masamichi Koike,...
created by uusjio | 2 years ago 177 views | 0 recommendations | 0 comments
"Less than 10 percent of pregnant women with musculoskeletal back pain were satisfied with the symptom relief they obtained, a U.S. study found.
The study, published in the Journal of Manipulative and Physiological Therapeutics, says despite the high prevalence of...
created by alaaron | 2 years ago 624 views | 0 recommendations | 0 comments
yeah we all know this is old stuff..relatively.. but again i want to highlight this amazing deal that's coming through!!Read on: WHITEHOUSE STATION, N.J.—Looking to enhance its position in the
nascent RNAi-based therapeutics market, Merck announced it would
acquire...
created by gamedruid | 2 years ago 277 views | 0 recommendations | 0 comments
Very recently in the Journal Nature...British scientists have taken an
important step toward preventing tumor growth by finding a way of
switching off a gene involved in cell division.
The Oxford University researchers say the mechanism involves a form
of ribonucleic acid, or...
created by gamedruid | 2 years ago 250 views | 0 recommendations | 0 comments